Cargando…

5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study

Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT(3)) blockade. Our aim was to assess if routine prophylac...

Descripción completa

Detalles Bibliográficos
Autores principales: Neumann, Claudia, Velten, Markus, Heik-Guth, Cornelia, Strizek, Brigitte, Wittmann, Maria, Hilbert, Tobias, Klaschik, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478381/
https://www.ncbi.nlm.nih.gov/pubmed/32899016
http://dx.doi.org/10.1097/MD.0000000000021864
_version_ 1783580037962792960
author Neumann, Claudia
Velten, Markus
Heik-Guth, Cornelia
Strizek, Brigitte
Wittmann, Maria
Hilbert, Tobias
Klaschik, Sven
author_facet Neumann, Claudia
Velten, Markus
Heik-Guth, Cornelia
Strizek, Brigitte
Wittmann, Maria
Hilbert, Tobias
Klaschik, Sven
author_sort Neumann, Claudia
collection PubMed
description Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT(3)) blockade. Our aim was to assess if routine prophylactic administration of the 5-HT(3) antagonist ondansetron (ODS) attenuates postspinal change in maternal blood pressure. Elective CS under SpA were retrospectively analyzed. Eighty parturients having routinely received 8 mg ODS prior to SpA were compared with 80 patients having not (control group). Mean arterial blood pressure significantly decreased from baseline to the postspinal period (P < .0001) without differences in blood pressure decreases between the 2 groups. This also applied to the heart rate. Overall use of cafedrine/theodrenaline was higher in the ODS group (0.8 (0.4–1.6) mL vs 0.8 (0–1.0) mL in the control group, P = .01). APGAR values showed a presumably clinically irrelevant decrease in control group compared with the ODS group. Our results suggest that routine administration of ODS in a dosage of 8 mg does not effectively attenuate postspinal change in maternal blood pressure during CS in our setting. Given the wide variability of anesthetic techniques, only large prospective and randomized multicenter trials will ultimately serve to elucidate this issue.
format Online
Article
Text
id pubmed-7478381
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74783812020-09-16 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study Neumann, Claudia Velten, Markus Heik-Guth, Cornelia Strizek, Brigitte Wittmann, Maria Hilbert, Tobias Klaschik, Sven Medicine (Baltimore) 3300 Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT(3)) blockade. Our aim was to assess if routine prophylactic administration of the 5-HT(3) antagonist ondansetron (ODS) attenuates postspinal change in maternal blood pressure. Elective CS under SpA were retrospectively analyzed. Eighty parturients having routinely received 8 mg ODS prior to SpA were compared with 80 patients having not (control group). Mean arterial blood pressure significantly decreased from baseline to the postspinal period (P < .0001) without differences in blood pressure decreases between the 2 groups. This also applied to the heart rate. Overall use of cafedrine/theodrenaline was higher in the ODS group (0.8 (0.4–1.6) mL vs 0.8 (0–1.0) mL in the control group, P = .01). APGAR values showed a presumably clinically irrelevant decrease in control group compared with the ODS group. Our results suggest that routine administration of ODS in a dosage of 8 mg does not effectively attenuate postspinal change in maternal blood pressure during CS in our setting. Given the wide variability of anesthetic techniques, only large prospective and randomized multicenter trials will ultimately serve to elucidate this issue. Lippincott Williams & Wilkins 2020-09-04 /pmc/articles/PMC7478381/ /pubmed/32899016 http://dx.doi.org/10.1097/MD.0000000000021864 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3300
Neumann, Claudia
Velten, Markus
Heik-Guth, Cornelia
Strizek, Brigitte
Wittmann, Maria
Hilbert, Tobias
Klaschik, Sven
5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
title 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
title_full 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
title_fullStr 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
title_full_unstemmed 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
title_short 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
title_sort 5-ht(3) blockade does not attenuate postspinal blood pressure change in cesarean section: a case-control study
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478381/
https://www.ncbi.nlm.nih.gov/pubmed/32899016
http://dx.doi.org/10.1097/MD.0000000000021864
work_keys_str_mv AT neumannclaudia 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy
AT veltenmarkus 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy
AT heikguthcornelia 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy
AT strizekbrigitte 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy
AT wittmannmaria 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy
AT hilberttobias 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy
AT klaschiksven 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy